Kinetics of Urinary Trypsin Inhibitor in Patients Undergoing Partial Hepatectomy

References

• Baumann H, Gauldie J. The acute phase response. Immunol Today 1994;15:74–80.
   PubMedGoogle Scholar
• Moshage H. Cytokines and the hepatic acute phase response. J Pathol 1997;181:257–66.
   PubMed Web of Science ®Google Scholar
• Midorikawa Y, Kubota K, Takayama T, Toyoda H, Ijichi M, Torzilli G, et al. A comparative study of postoperative complications after hepatectomy in patients with and without chronic liver disease. Surgery 1999;126:484–91.
   PubMed Web of Science ®Google Scholar
• Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, et al. Extended resections for hilar cholangiocarcinoma. Ann Surg 1999;230:808–19.
   PubMed Web of Science ®Google Scholar
• Iwatsuki S, Shaw BW, Starzl TE. Experience with 150 liver resections. Ann Surg 1983;197: 247–53.
   Google Scholar
• Nagao T, Inoue S, Mizuta T, Saito H, Kawano N, Morioka Y. One hundred hepatic resections. Ann Surg 1985;202:42–9.
   PubMedGoogle Scholar
• Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y, et al. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients. Arch Surg 1999;134:984–92.
   PubMedGoogle Scholar
• Fan ST, Lo CM, Liu CL, Lam CM, Yuen WK, Yeung C, et al. Hepatectomy for hepatocellular carcinoma: toward zero hospital mortality. Ann Surg 1999;229:322–30.
   PubMed Web of Science ®Google Scholar
• Wollheim FA, Pihl B, Ekelund G, Aronsen KF. Immunoglobulins and acute phase reactants in man after major hepatic resection. Scand J Gastroenterol 1969;4:249–53.
   PubMedGoogle Scholar
• Ohzato H, Yoshizaki K, Nishimoto N, Ogata A, Tagoh H, Monden M, et al. Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery 1992;111:201–9.
   PubMed Web of Science ®Google Scholar
• Kimura F, Miyazaki M, Suwa T, Kakizaki S, Itoh H, Kaiho T, et al. Increased serum interleukin-6 level and reduction of hepatic acute-phase response after major hepatectomy. Eur Surg Res 1996;28:96–103.
   PubMedGoogle Scholar
• Dillard GHL. The trypsin inhibitor of the urine in health and disease. J Lab Clin Med 1950;36:266–71.
   PubMed Web of Science ®Google Scholar
• Shulman NR. Proteolytic inhibitor with anticoagulant activity separated from human urine and plasma. J Biol Chem 1955; 213:655–71.
   PubMed Web of Science ®Google Scholar
• Faarvang HJ. Physiological and patho-physiological variations, relation to pituitary-adrenocortical hormones, and to serum trypsin inhibitor. Scand J Clin Lab Invest 1965;17 Suppl 83:178.
   PubMedGoogle Scholar
• Odum L, Hansen-Nord G, Byrjalsen I. Human inter-alphatrypsin inhibitor and immunologically related inhibitors investigated by quantitative immunoelectrophoresis: II. pathological conditions. Clin Chim Acta 1987;162:189–98.
   PubMed Web of Science ®Google Scholar
• Kuwajima S, Matsui T, Kitahashi S, Kishida T, Noda T, Izumi Y, et al. Automated measurement of trypsin inhibitor in urine with a centrifugal analyzer: comparison with other acute phase reactants. Clin Biochem 1990;23:167–71.
   PubMed Web of Science ®Google Scholar
• Odaka A, Murata N, Tada M, Idezuki Y. Urinary trypsin inhibitor (UTI) levels in patients undergoing gastroenterological surgery. In: Passaro E Jr, Condon RE, Basoli A, editors. Collegium International Chirurgiae Digestivae 14th World Congress. Bologna: Monduzzi Editore; 1994. p. 137–40.
   Google Scholar
• Jonsson BM, Loffler C, Ohlsson K. Human granulocyte elastase is inhibited by the urinary trypsin inhibitor. Hoppe-Seyler’ s Z Physiol Chem 1982;363:1167–75.
   PubMedGoogle Scholar
• Potempa J, Kwon K, Chawla R, Travis L. Inter-alpha-trypsin inhibitor: inhibition spectrum of native and derived forms. J Biol Chem 1989;264:15109–14.
   PubMedGoogle Scholar
• Tani T, Aoki H, Yoshioka T, Lin KJ, Kodama M. Treatment of septic shock with a protease inhibitor in a canine model: a prospective, randomized, controlled trial. Crit Care Med 1993; 21:925–30.
   Google Scholar
• Ohnishi H, Kosuzume H, Ashida Y, Kato K, Honjo I. Effects of urinary trypsin inhibitor on pancreatic enzymes and experimental acute pancreatitis. Dig Dis Sci 1984;29:26–32.
   Google Scholar
• Tani S, Otsuki M, Itoh H, Nakamura T, Fujii M, Okabayashi Y, et al. The protective effect of the trypsin inhibitor ulinastatin on cerulein-induced acute pancreatitis in rats. Pancreas 1988;3: 471–6.
   PubMedGoogle Scholar
• Hirano T, Manabe T, Tobe T. Effect of urinary trypsin inhibitor on pancreatic cellular and lysosomal fragility in cerulein-induced acute pancreatitis in rats. Dig Dis Sci 1993;38:660–4.
   Google Scholar
• Nielsen NC. Spectrophotometric determination of ICG in plasma especially with a view to an improved correction for blank density. Scand J Clin Lab Invest 1963;15:613–21.
   PubMed Web of Science ®Google Scholar
• Makuuchi M, Hasegawa H, Yamazaki S. Ultrasonically guided subsegmentectomy. Surg Gynecol Obstet 1985;161:346–50.
   PubMedGoogle Scholar
• Makuuchi M, Mori T, Gunven P, Yamazaki S, Hasegawa H. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet 1987;164:155–8.
   Google Scholar
• Jonsson-Berling BM, Ohlsson K, Rosengren M. Radioimmunological quantitation of the urinary trypsin inhibitor in normal blood and urine. Biol Chem Hoppe-Seyler 1989;370:1157–61.
   PubMed Web of Science ®Google Scholar
• Murata A, Ogawa M, Yasuda T, Nishijima J, Oka Y, Ohmachi Y, et al. Serum interleukin 6, C-reactive protein and pancreatic secretory trypsin inhibitor (PSTI) as acute phase reactants after major thoraco-abdominal surgery. Immunol Invest 1990;19: 271–8.
   PubMed Web of Science ®Google Scholar
• Lindqvist A, Bratt T, Altieri M, Kastern W, Akerstrom B. Rat α1-microglobulin: co-expression in liver with the light chain of inter-α-trypsin inhibitor. Biochim Biophys Acta 1992;1130: 63–7.
   Google Scholar
• Salier JP, Chan P, Raguenez G, Zwingman T, Erickson RP. Developmentally regulated transcription of the four liver-specific genes for inter-α-inhibitor family in mouse. Biochem J 1993;296:85–91.
   Google Scholar
• Wakayama T, Mizushima S, Hirose J, Iseki S. Urinary trypsin inhibitor: production in the liver and reabsorption in the kidney of the rat. Acta Histochem Cytochem 1996;29:227–36.
   Google Scholar
• Kaumeyer JF, Pollazi JO, Kotick MP. The mRNA for a proteinase inhibitor related to the HI-30 domain of inter-α-trypsin inhibitor also encodes α-1-microglobulin (protein HC). Nucleic Acids Res 1986;14: 7839–50.
   Google Scholar
• Salier JP, Diarra-Mehrpour M, Sesboue R, Bourguignon J, Benarous R, Ohkubo I, et al. Isolation and characterization of cDNAs encoding the heavy chain of human inter-α-trypsin inhibitor (IαTI): unambiguous evidence for multipolypeptide chain structure of IaTI. Proc Natl Acad Sci USA 1987;84: 8272–6.
   PubMed Web of Science ®Google Scholar
• Balduyck M, Laroui S, Mizon J. A proteoglycan related to the urinary trypsin inhibitor (UTI) links the two heavy chains of inter-α-trypsin inhibitor. Biol Chem Hoppe-Seyler 1989;370: 329–36.
   Google Scholar
• Hochstrasser K, Bretzel G, Feuth H, Hilla W, Lempart K. The inter-α-trypsin inhibitor as precursor of the acid-stable proteinase inhibitors in human serum and urine. Hoppe-Seylers Z Physiol Chem 1976;357:153–62.
   Google Scholar
• Sumi H, Takada Y, Takada A. Studies on human urinary trypsin inhibitor. 1. Its modification on treatment of urine with acid. Thromb Res 1977;11: 747–54.
   Google Scholar
• Lindstrom KE, Blom A, Johnsson E, Haraldsson B, Fries E. High glomerular permeability of bikunin despite similarity in charge and hydrodynamic size to serum albumin. Kidney Int 1997;51:1053–8.
   Google Scholar
• Yamasaki F, Shinkawa T, Watanabe M, Mizota M. Uptake of human urinary trypsin inhibitor by the kidney epithelial cell line, LLC-PK1. Pflug Arch Eur J Phy 1996;433:9–15.
   PubMedGoogle Scholar
• Jonsson-Berling BM, Ohlsson K. Distribution and elimination of intravenously injected urinary trypsin inhibitor. Scand J Clin Lab Invest 1991;51:549–57.
   PubMed Web of Science ®Google Scholar
• Maack T, Park CH, Camargo JF. Renal filtration, transport and metabolism of proteins. In: Seldin DW, Giebisch G, editors. The kidney: physiology and pathophysiology. 2nd ed. New York: Raven Press; 1992. p. 3005–38.
   Google Scholar
• Wortel CH, van Deventer SJH, Aarden LA, Lygidakis NJ, Buller HR, Hoek FJ, et al. Interleukin-6 mediates host defense response induced by abdominal surgery. Surgery 1993;114:564–70.
   PubMed Web of Science ®Google Scholar
• Fischer CL, Gill C, Forrester MG, Nakamura R. Quantitation of ‘acute-phase proteins’ postoperatively. Value in detection and monitoring of complications. Am J Clin Pathol 1976;66:840–6.
   PubMed Web of Science ®Google Scholar
• Ghoneim AT, McGoldrick J, Ionescu MI. Serial C-reactive protein measurements in infective complications following cardiac operation: evaluation and use in monitoring response to therapy. Ann Thorac Surg 1982;34:166–75.
   Google Scholar
• Mustard RA Jr, Bohnen JM, Haseeb S, Kasina R. C-reactive protein levels predict postoperative septic complications. Arch Surg 1987;122:69–73.
   PubMedGoogle Scholar
• Niskanen RO, Korkala O, Pammo H. Serum C-reactive protein levels after total hip and knee arthroplasty. J Bone Joint Surg Br 1996;78:431–3.
   Google Scholar
• McCormick SR, Baumgarten A. C-reactive protein as early predictor of liver viability after transplantation. Lancet 1984;2: 1478.
   PubMedGoogle Scholar